Study for using azithromycin with artemisinin derivatives in the treatment of imported Pv and Po malaria patients in Shanglin, Guangxi

Status

Recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR1900021687

Enrollment

Unknown

Registered

2019-03-05

Start date

2017-01-01

Completion date

Unknown

Last updated

2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Malaria

Interventions

Control group:WHO recommended malaria treatment strategy

Experiment group:Azithromycin and Artesunate

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Defined Pv and Po malaria patients.

Exclusion criteria

Exclusion criteria: Other malaria patients.

Design outcomes

Primary

Measure	Time frame
finger-prick blood Slides;temperature;	—

Countries

China

Contacts

Public ContactQin Pi'en

Shanglin County People's Hospital

1695588725@qq.com+86 13768598842

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026